Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Position statement on ethics, equipoise and research on charged particle radiation therapy.
Sheehan M, Timlin C, Peach K, Binik A, Puthenparampil W, Lodge M, Kehoe S, Brada M, Burnet N, Clarke S, Crellin A, Dunn M, Fossati P, Harris S, Hocken M, Hope T, Ives J, Kamada T, London AJ, Miller R, Parker M, Pijls-Johannesma M, Savulescu J, Short S, Skene L, Tsujii H, Tuan J, Weijer C. Sheehan M, et al. Among authors: brada m. J Med Ethics. 2014 Aug;40(8):572-5. doi: 10.1136/medethics-2012-101290. Epub 2013 Sep 17. J Med Ethics. 2014. PMID: 24045770
Current clinical evidence for proton therapy.
Brada M, Pijls-Johannesma M, De Ruysscher D. Brada M, et al. Cancer J. 2009 Jul-Aug;15(4):319-24. doi: 10.1097/PPO.0b013e3181b6127c. Cancer J. 2009. PMID: 19672149 Review.
Charged particles in radiotherapy: a 5-year update of a systematic review.
De Ruysscher D, Mark Lodge M, Jones B, Brada M, Munro A, Jefferson T, Pijls-Johannesma M. De Ruysscher D, et al. Among authors: brada m. Radiother Oncol. 2012 Apr;103(1):5-7. doi: 10.1016/j.radonc.2012.01.003. Epub 2012 Feb 10. Radiother Oncol. 2012. PMID: 22326572 Free article. Review.
The treatment of malignant cerebral tumours.
Short SC, Brada M. Short SC, et al. Among authors: brada m. Hosp Med. 2000 Nov;61(11):772-7. doi: 10.12968/hosp.2000.61.11.1462. Hosp Med. 2000. PMID: 11198745 Review.
Temozolomide as second-line chemotherapy for relapsed gliomas.
Trent S, Kong A, Short SC, Traish D, Ashley S, Dowe A, Hines F, Brada M. Trent S, et al. Among authors: brada m. J Neurooncol. 2002 May;57(3):247-51. doi: 10.1023/a:1015788814667. J Neurooncol. 2002. PMID: 12125988
Thalidomide as an anti-angiogenic agent in relapsed gliomas.
Short SC, Traish D, Dowe A, Hines F, Gore M, Brada M. Short SC, et al. Among authors: brada m. J Neurooncol. 2001 Jan;51(1):41-5. doi: 10.1023/a:1006414804835. J Neurooncol. 2001. PMID: 11349879 Clinical Trial.
ESTRO-ACROP guideline "target delineation of glioblastomas".
Niyazi M, Brada M, Chalmers AJ, Combs SE, Erridge SC, Fiorentino A, Grosu AL, Lagerwaard FJ, Minniti G, Mirimanoff RO, Ricardi U, Short SC, Weber DC, Belka C. Niyazi M, et al. Among authors: brada m. Radiother Oncol. 2016 Jan;118(1):35-42. doi: 10.1016/j.radonc.2015.12.003. Epub 2016 Jan 6. Radiother Oncol. 2016. PMID: 26777122
244 results